DE3750897D1 - Verfahren für Umwandlung von menschlichem Insulin-Vorläufer in menschliches Insulin. - Google Patents

Verfahren für Umwandlung von menschlichem Insulin-Vorläufer in menschliches Insulin.

Info

Publication number
DE3750897D1
DE3750897D1 DE3750897T DE3750897T DE3750897D1 DE 3750897 D1 DE3750897 D1 DE 3750897D1 DE 3750897 T DE3750897 T DE 3750897T DE 3750897 T DE3750897 T DE 3750897T DE 3750897 D1 DE3750897 D1 DE 3750897D1
Authority
DE
Germany
Prior art keywords
human insulin
converting
precursor
insulin precursor
converting human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3750897T
Other languages
English (en)
Other versions
DE3750897T2 (de
Inventor
Bruce Hill Frank
Richard Eugene Heiney
Walter Francis Prouty
Mark Robert Walden
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of DE3750897D1 publication Critical patent/DE3750897D1/de
Publication of DE3750897T2 publication Critical patent/DE3750897T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE3750897T 1986-10-14 1987-10-13 Verfahren für Umwandlung von menschlichem Insulin-Vorläufer in menschliches Insulin. Expired - Fee Related DE3750897T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US91793986A 1986-10-14 1986-10-14

Publications (2)

Publication Number Publication Date
DE3750897D1 true DE3750897D1 (de) 1995-02-02
DE3750897T2 DE3750897T2 (de) 1995-05-18

Family

ID=25439543

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3750897T Expired - Fee Related DE3750897T2 (de) 1986-10-14 1987-10-13 Verfahren für Umwandlung von menschlichem Insulin-Vorläufer in menschliches Insulin.

Country Status (26)

Country Link
US (1) US5457066A (de)
EP (1) EP0264250B1 (de)
JP (1) JP2634176B2 (de)
KR (1) KR970003519B1 (de)
CN (1) CN1029131C (de)
AR (1) AR243608A1 (de)
AT (1) ATE115962T1 (de)
AU (1) AU595934B2 (de)
CA (1) CA1339955C (de)
CY (1) CY1830A (de)
DE (1) DE3750897T2 (de)
DK (1) DK175266B1 (de)
EG (1) EG18520A (de)
ES (1) ES2065321T3 (de)
GR (1) GR3015143T3 (de)
HK (1) HK39495A (de)
HU (1) HU204572B (de)
IE (1) IE65972B1 (de)
IL (1) IL84110A (de)
MX (1) MX168305B (de)
NZ (1) NZ222082A (de)
PH (1) PH26471A (de)
PT (1) PT85892B (de)
RU (1) RU1829939C (de)
SG (1) SG14795G (de)
ZA (1) ZA877505B (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5130236A (en) * 1989-12-07 1992-07-14 Eli Lilly And Company Process for producing des(64,65)-proinsulin
FI103805B (fi) 1990-09-05 1999-09-30 Hoechst Ag Menetelmä preproinsuliinien hydroloimiseksi
CZ342492A3 (en) * 1991-11-26 1993-06-16 Lilly Co Eli Derivatives of tri-arginine insulin, process of their preparation and a pharmaceutical composition in which said derivatives are comprised
CA2102673A1 (en) * 1992-11-13 1994-05-14 Michael G. Greaney Expression vectors for bovine trypsin and trypsinogen and host cells transformed therewith
US6001604A (en) * 1993-12-29 1999-12-14 Bio-Technology General Corp. Refolding of proinsulins without addition of reducing agents
US6068993A (en) * 1997-07-02 2000-05-30 Biobras Sa Vector for expression of heterologous protein and methods for extracting recombinant protein and for purifying isolated recombinant insulin
US6087558A (en) * 1998-07-22 2000-07-11 Prodigene, Inc. Commercial production of proteases in plants
CA2328614C (en) 1999-02-12 2012-06-26 Biostream, Inc. Matrices for drug delivery and methods for making and using the same
US7169889B1 (en) 1999-06-19 2007-01-30 Biocon Limited Insulin prodrugs hydrolyzable in vivo to yield peglylated insulin
US20020164712A1 (en) * 2000-12-11 2002-11-07 Tonghua Gantech Biotechnology Ltd. Chimeric protein containing an intramolecular chaperone-like sequence
EP1346726A4 (de) * 2000-12-25 2004-09-15 Shiseido Co Ltd Parfumzusammenstellung die das sympathetische system stimulieren
US7060675B2 (en) 2001-02-15 2006-06-13 Nobex Corporation Methods of treating diabetes mellitus
US6867183B2 (en) 2001-02-15 2005-03-15 Nobex Corporation Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
US6858580B2 (en) * 2001-06-04 2005-02-22 Nobex Corporation Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US6828297B2 (en) 2001-06-04 2004-12-07 Nobex Corporation Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US7713932B2 (en) 2001-06-04 2010-05-11 Biocon Limited Calcitonin drug-oligomer conjugates, and uses thereof
US6835802B2 (en) * 2001-06-04 2004-12-28 Nobex Corporation Methods of synthesizing substantially monodispersed mixtures of polymers having polyethylene glycol moieties
US6828305B2 (en) 2001-06-04 2004-12-07 Nobex Corporation Mixtures of growth hormone drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US6713452B2 (en) 2001-06-04 2004-03-30 Nobex Corporation Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US7312192B2 (en) 2001-09-07 2007-12-25 Biocon Limited Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
US7166571B2 (en) 2001-09-07 2007-01-23 Biocon Limited Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
US6913903B2 (en) 2001-09-07 2005-07-05 Nobex Corporation Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
US7196059B2 (en) 2001-09-07 2007-03-27 Biocon Limited Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
KR100925381B1 (ko) * 2001-11-19 2009-11-09 노보 노르디스크 에이/에스 인슐린 화합물의 제조 방법
EP1572720A4 (de) * 2002-05-24 2008-12-24 Nps Allelix Corp Verfahren zur enzymatischen herstellung von glp-2-(1-33)- und glp-2-(1-34)-peptiden
DE60334912D1 (de) * 2002-05-24 2010-12-23 Medtronic Inc Polypeptid-spaltungsprozess
WO2003099853A2 (en) * 2002-05-24 2003-12-04 Restoragen, Inc. Petide amidation process
WO2003105768A2 (en) * 2002-06-13 2003-12-24 Nobex Corporation Methods of reducing hypoglycemic episodes in the treatment of diabetes mellitus
DE10235168A1 (de) 2002-08-01 2004-02-12 Aventis Pharma Deutschland Gmbh Verfahren zur Reinigung von Preproinsulin
EP1704234B1 (de) * 2003-11-21 2012-01-18 NPS Pharmaceuticals, Inc. Herstellung von glucagonähnlichem peptid 2 und analogen
DE602004025192D1 (de) * 2003-12-05 2010-03-11 Roche Diagnostics Gmbh Rekombinante Carboxypeptidase B und ihre Aufreinigung
EP2626368B1 (de) 2004-07-19 2016-12-21 Biocon Limited Insulinoligomerkonjugate, Formulierungen und Verwendungen davon
BRPI0818004B8 (pt) 2007-10-16 2021-05-25 Biocon Ltd composição farmacêutica sólida administrável por via oral e o processo da mesma.
BRPI0823004B8 (pt) * 2008-08-07 2021-05-25 Biocon Ltd processo para preparação de compostos de insulina
WO2012104099A1 (en) * 2011-02-04 2012-08-09 Glucometrix Ag Process for the production of recombinant trypsin
WO2012115640A1 (en) 2011-02-23 2012-08-30 Elona Biotechnologies Liquid insulin- containing compositions and methods of making the same
JP2018531007A (ja) * 2015-09-24 2018-10-25 ハンミ ファーマシューティカル カンパニー リミテッド インスリンの製造方法
KR20200080747A (ko) * 2018-12-27 2020-07-07 주식회사 폴루스 인슐린 전구체의 인슐린 효소 전환용 조성물 및 이를 이용하여 인슐린 전구체를 인슐린으로 전환하는 방법
WO2023225534A1 (en) 2022-05-18 2023-11-23 Protomer Technologies Inc. Aromatic boron-containing compounds and related insulin analogs

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5756878A (en) * 1980-09-22 1982-04-05 Sharp Corp Cleaning device
DK149824C (da) * 1982-01-22 1987-03-16 Carlsberg Biotechnology Ltd Fremgangsmaade til enzymatisk udskiftning af b-30 aminosyrer i insuliner

Also Published As

Publication number Publication date
EG18520A (en) 1993-04-30
SG14795G (en) 1995-06-16
US5457066A (en) 1995-10-10
DK175266B1 (da) 2004-08-02
PT85892A (en) 1987-11-01
AU7952887A (en) 1988-04-21
EP0264250A2 (de) 1988-04-20
CA1339955C (en) 1998-07-14
CN1029131C (zh) 1995-06-28
ES2065321T3 (es) 1995-02-16
JP2634176B2 (ja) 1997-07-23
HK39495A (en) 1995-03-24
PT85892B (pt) 1990-07-31
CY1830A (en) 1995-12-01
HU204572B (en) 1992-01-28
NZ222082A (en) 1989-08-29
KR880005262A (ko) 1988-06-28
EP0264250A3 (en) 1990-03-21
AR243608A1 (es) 1993-08-31
ATE115962T1 (de) 1995-01-15
MX168305B (es) 1993-05-17
JPS63105695A (ja) 1988-05-10
DE3750897T2 (de) 1995-05-18
PH26471A (en) 1992-07-27
HUT46363A (en) 1988-10-28
DK528487D0 (da) 1987-10-09
IE65972B1 (en) 1995-11-29
GR3015143T3 (en) 1995-05-31
IE872743L (en) 1988-04-14
IL84110A0 (en) 1988-03-31
RU1829939C (ru) 1993-07-23
AU595934B2 (en) 1990-04-12
DK528487A (da) 1988-04-15
IL84110A (en) 1992-11-15
KR970003519B1 (ko) 1997-03-18
EP0264250B1 (de) 1994-12-21
CN87107019A (zh) 1988-04-27
ZA877505B (en) 1989-05-30

Similar Documents

Publication Publication Date Title
DE3750897T2 (de) Verfahren für Umwandlung von menschlichem Insulin-Vorläufer in menschliches Insulin.
DE3482656D1 (de) Durch die haut in ein gefaess einzufuehrende hochleistungsblutpumpe.
NO884170D0 (no) Katalytisk omdanningsprosess.
ATE63056T1 (de) Kontinuierliches verfahren zum tablettieren.
DE3783160T2 (de) Hartloetverfahren.
DE3672284D1 (de) Stromloses plattierungsverfahren.
DE3785617T2 (de) Immunassay-prozess.
DE3765292D1 (de) Hydroumwandlungsverfahren.
NO865263D0 (no) Lavviskos hoeymolekylaer filtersteriliserbar hyaluronsyre.
DE3777790D1 (de) Verfahren zur herstellung von acrylsaeure.
DE3750881D1 (de) Schmelzreduktionsverfahren.
DE3751259T2 (de) Kurvenerzeugungsverfahren.
DE3785603D1 (de) Produktion von epsilon-kaprolaktam.
DE3789052D1 (de) Mittel zur Verbesserung der Haftung.
DE3863304D1 (de) Herstellungsverfahren von methanol und in diesem verfahren zu verwendende katalysatorzusammenstellung.
DE3482333D1 (de) Zahnbauart zur vermeidung von scherbeanspruchungen.
DE3785530D1 (de) Verfahren zur herstellung von l-arginin.
NO884172D0 (no) Katalytisk omdanningsprosess.
DE3676804D1 (de) Verfahren zur umwandlung eines 1,1,1-trifluoralkans in ein 1,1-difluoralken.
DE3787855T2 (de) Verfahren zur rückkehr zum ursprung.
MX159205A (es) Metodo mejorado de conversion catalitica de hidrocarburos en etapas multiples
DE3877008D1 (de) Geraet zur sukzessiven umwandlung von zeitperioden in spannung.
FI884766A (fi) Syrakatalyserad process.
KR880007805A (ko) 전해처리조
AT359023B (de) Verfahren zur umwandlung von glucose in fructose

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee